EmoLED Mini-Series Online
- Kerr Biotech
- Jul 21, 2021
- 1 min read
Updated: May 4, 2024
Earlier this month the Emoled team based in Italy announced a free 4-part webinar mini-series featuring clinicians from Europe and Asia sharing their clinical experience with the EmoLED device and how blue-light photobiomodulation has impacted their own patients with chronic wounds.

"The overwhelming interest we received from local wound management clinicians confirms that there is a growing appetite to explore new modalities in wound management as the prevalence of non-healing wounds in Australia worsens. The imminent publication of EmoLEDs BLUR trial is going to push blue-light therapy into the market ahead of schedule"
The science of phototherapies is already well accepted in dermatology, now clinical experience in non-healing wounds is opening up a new frontier for patients in need.
Contact us to access a recording of the webinar or for more information on future events
The Event Overview
The event was opened by Dr Stefano Gasperini, the medical director of Emoled SRL. Dr Gasperini provided a succinct overview of Photobiomodulation with Blue LED Light in wound care therapy, explaining its mode of action and the origins of the EmoLED device.
Dr Marino Ciliberti presented results from the BLUR clinical study (Blue Light for Ulcer Reduction), showing evidence of the contribution of Blue Light to the healing of hard-to-heal wounds focusing predominantly in venous leg ulcers (VLU)
A/Prof Tjun Yip Tung shared his experience of EmoLED treatment of VLU ulcers based in Singapore reporting encouraging observations such as reductions in exudate
Dr Carla Pezzuto discussed the use of EmoLED for managing pressure ulcers, sharing the results of her preliminary experience in patients with spinal cord lesions.

Comments